CytoDyn Inc. (CYDY)
OTCMKTS: CYDY · Delayed Price · USD
0.141
-0.001 (-0.35%)
Jul 26, 2024, 3:59 PM EDT - Market closed
CytoDyn Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Year Ending | TTM | May 31, 2023 | May 31, 2022 | May 31, 2021 | May 31, 2020 | May 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 0.27 | - | - | - | Upgrade
|
| Cost of Revenue | - | 20.63 | 73.54 | 5.03 | - | - | Upgrade
|
| Gross Profit | - | -20.63 | -73.28 | -5.03 | - | - | Upgrade
|
| Selling, General & Admin | 10.55 | 17.14 | 44.3 | 34.32 | 19.97 | 12.12 | Upgrade
|
| Research & Development | 4.62 | 2.63 | 27.04 | 53.4 | 52.64 | 42.49 | Upgrade
|
| Depreciation & Amortization | 0.04 | 0.18 | 0.78 | 1.8 | 2.03 | 1.25 | Upgrade
|
| Operating Expenses | 15.2 | 19.94 | 72.13 | 89.52 | 74.65 | 55.85 | Upgrade
|
| Operating Income | -15.2 | -40.58 | -145.4 | -94.55 | -74.65 | -55.85 | Upgrade
|
| Interest Expense | -19.93 | -25.19 | -24.18 | -22.11 | -33.25 | -3.31 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.87 | -8.75 | - | - | -9.54 | 1.67 | Upgrade
|
| EBT Excluding Unusual Items | -37 | -74.51 | -169.59 | -116.66 | -117.44 | -57.49 | Upgrade
|
| Asset Writedown | - | - | - | -10.05 | - | - | Upgrade
|
| Legal Settlements | - | - | -3.85 | -10.63 | -22.5 | - | Upgrade
|
| Other Unusual Items | -14.69 | -5.31 | -37.38 | -39.13 | - | -1.52 | Upgrade
|
| Pretax Income | -51.69 | -79.82 | -210.82 | -176.47 | -139.94 | -59.01 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -2.83 | Upgrade
|
| Net Income | -51.69 | -79.82 | -210.82 | -176.47 | -139.94 | -56.19 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.48 | 6.91 | 1.63 | 1.69 | 0.71 | - | Upgrade
|
| Net Income to Common | -53.17 | -86.74 | -212.45 | -178.15 | -140.64 | -56.19 | Upgrade
|
| Shares Outstanding (Basic) | 944 | 837 | 677 | 588 | 421 | 272 | Upgrade
|
| Shares Outstanding (Diluted) | 944 | 837 | 677 | 588 | 421 | 272 | Upgrade
|
| Shares Change (YoY) | 19.91% | 23.58% | 15.20% | 39.54% | 54.78% | 55.55% | Upgrade
|
| EPS (Basic) | -0.06 | -0.10 | -0.31 | -0.30 | -0.33 | -0.21 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.10 | -0.31 | -0.30 | -0.33 | -0.21 | Upgrade
|
| Free Cash Flow | -12.74 | -25.11 | -77.72 | -117.7 | -68.85 | -50.49 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.11 | -0.20 | -0.16 | -0.19 | Upgrade
|
| Operating Margin | - | - | -54663.16% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | -29219.17% | - | - | - | Upgrade
|
| EBITDA | -15.17 | -40.4 | -144.62 | -92.75 | -72.61 | -54.61 | Upgrade
|
| D&A For EBITDA | 0.04 | 0.18 | 0.78 | 1.8 | 2.03 | 1.25 | Upgrade
|
| EBIT | -15.2 | -40.58 | -145.4 | -94.55 | -74.65 | -55.85 | Upgrade
|
Source: S&P Capital IQ. Standard template.